📜3-(2-噻吩)丙酸置于氯化亚砜体系中,化学反应 3.0H,反应生成3-(2-噻吩)丙酸甲酯 参考文献:Synthesis Of Selective Srpk-1 Inhibitors: Novel Tricyclic Quinoxaline Derivatives 标题:Synthesis Of Selective Srpk-1 Inhibitors: Novel Tricyclic Quinoxaline Derivatives 摘要:Sr Protein-Specific Kinase-1 (Srpk-1) Has Been Identified As A Validated Target For Hepatitis B Virus (Hbv). A Series Of Novel Tricyclic Quinoxaline Derivatives Was Designed And Synthesised As Potential Kinase Inhibitory Antiviral Agents And Was Found To Be Active And Selective For Srpk-1 Kinase. Most Of These Novel Compounds Have Drug-Like Properties According To Experimentally Determined Log P And Log S Values. (C) 2005 Elsevier Ltd. All Rights Reserved. Doi:10.1016/j.Bmcl.2005.04.064
专利号:US-4563537-A 优先权日:1982-09-27 标题:Synthesis of thiophene-containing prostaglandin endoperoxide apparatus 发明人:LAROCK RICHARD C 权利人:UNIV IOWA STATE RES FOUND INC 摘要:New organopalladium reactions involving the addition of thienylpalladium compounds to strained bicyclic alkenes, and subsequent chain extension reactions employing the chemistry of organopalladium compounds are disclosed. By these techniques a large number of bicyclic prostaglandin analogs are prepared, which are useful as inhibitors of arachidonic acid induced blood platelet aggregation, and are specific inhibitors of thromboxane synthetase.
专利号:US-4520207-A 优先权日:1982-09-27 标 题:Synthesis of thiophene-containing prostaglandin endoperoxide analogs 发明人:LAROCK RICHARD C 权利人:UNIV IOWA STATE RES FOUND INC 摘要:New organopalladium reactions involving the addition of thienylpalladium compounds to strained bicyclic alkenes, and subsequent chain extension reactions employing the chemistry of organopalladium compounds are disclosed. By these techniques a large number of bicyclic prostaglandin analogs are prepared, which are useful as inhibitors of arachidonic acid induced blood platelet aggregation, and are specific inhibitors of thromboxane synthetase.
专利号:RU-2124513-C1 优先权日:1991-08-14 标题:(e)-3-[2-n-butyl-1-{(4-carboxyphenyl)-methyl}-1h-imidazole-5- -yl]-2-(2-thienyl)-methyl-2-propenoic acid methanesulfonate, method of its synthesis, pharmaceutical composition based on thereof